We now seek comments on a draft update of the GM Secondary Prevention Lipid Pathway. The update aims to gain consensus on the appropriate use of lipid-lowering medication. and resolve issues related to medication sequences, patient management pathways, and uncertainty regarding treatment targets.
This consultation will run for six weeks and closes at 5pm on Thursday 3rd April 2025. To take part, visit the consultations page.